Ellsworth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,682
Closed -$3.12M 152
2021
Q1
$3.12M Buy
+8,682
New +$2.79M 1.87% 8
2020
Q4
Sell
-4,619
Closed -$1.24M 127
2020
Q3
$1.24M Sell
4,619
-7
-0.2% -$1.88K 1.24% 34
2020
Q2
$1.22M Buy
+4,626
New +$1.23M 1.33% 33

Other funds holding ELV

Ellsworth Advisors's ELV Position: Q2 2021 in Review

Ellsworth Advisors sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 8,682 shares — an estimated $3.12M sold.

Ellsworth Advisors first reported a position in ELV in Q2 2020 and held it in 3 quarters. The position peaked at $3.12M in Q1 2021. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • Ellsworth Advisors reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • Ellsworth Advisors sold 8,682 Elevance Health shares in Q2 2021, an estimated $3.12M.
  • Ellsworth Advisors first reported a position in Elevance Health in Q2 2020 and held it in 3 quarters.
  • Ellsworth Advisors's Elevance Health position peaked at $3.12M in Q1 2021.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Ellsworth Advisors's 13F filing for Q2 2021, filed 19 Jul 2021.